I Am Diagnosed With Triple-Negative Breast Cancer
In triple-negative disease, breast cancer does not grow in the presence of three known receptors that we can target for treatment: the estrogen receptor, the progesterone receptor and the HER2 receptor. Between 15 and 20 percent of breast cancers are found to be triple-negative. You may hear people call TNBC aggressive and hard to treat, but chemotherapy has been found to be effective against these cancers. As a person with triple-negative breast cancer, you may have specific concerns about treatment options, chemotherapy side effects and risks for recurrence. In this section, explore your unique needs as you cope with this diagnosis.
We are grateful to the Triple Negative Breast Cancer Foundation for their support and contributions to the content found in this section.